Antiviral lectin and uses thereof
AssigneeAcademia Sinica
InventorsChe Ma, Yo-Min Liu, Jia-Tsrong Jan
Life of this patent
Estimating the term…
Abstract
The present invention relates to antiviral lectin and uses thereof. Particularly, the present invention relates to a complex-type (CX-type) and/or hybrid-type (HY-type) glycan binding lectin for use in treating or preventing influenza virus infection. The present invention also provides a method for treating or preventing influenza virus infection by administrating to a subject in need said lectin or a composition comprising the same.
Claims13
A method for treating influenza virus infection comprising administering to a subject in need thereof an effective amount of a complex-type or hybrid-type glycan binding lectin or a composition comprising the same, wherein the lectin is an Flt3 receptor interacting lectin (FRIL) protein from Lablab purpureous.
A method for treating influenza virus infection comprising administering to a subject in need thereof an effective amount of an Flt3 receptor interacting lectin (FRIL) protein from Lablab purpureous or a composition comprising the same, wherein the influenza virus infection is caused by an influenza virus strain selected from the group consisting of A/California/7/2009, A/New Caledonia/20/1999, A/WSN/1933, A/Victoria/361/2011, A/Wisconsin/67/2005, A/Vietnam/1194/2004,A/Shanghai/02/2013, B/Brisbane/60/2008, B/Florida/4/2006, B/Malaysia/2506/2004 and any combination thereof.
Dependencies are inferred from the claim text.